LTR 134: James Pink on Responsible AI and Future of MedTech Safety

Summary“With great power comes great responsibility. The innovation in AI is incredible, but our assurance models must catch up if we’re to keep patients safe”In this thought provoking Let’s Talk Risk! conversation, host Dr. Naveen Agarwal welcomes James Pink, a global leader in medical device safety, risk, and regulatory strategy. James shares his deeply personal journey, from clinical engineering and auditing, to his life-altering health experience that reinforced his passion for patient safety.Together they unpack how artificial intelligence is transforming healthcare innovation, the gaps in current assurance models, and the urgent need for literacy, accountability, and human-in-the-loop oversight.The discussion highlights contrasts between EU and U.S. regulatory approaches, the concept of AI assurance, and why quality professionals must evolve from compliance guardians to informed custodians of safety in an AI-enabled world.Listen to the full 30-minute podcast or jump to a section of interest listed below. Chapters00:00 Welcome & Introduction 02:00 A Personal Story 05:00 AI’s Transformative Power 07:00 Regulatory Divergence 11:30 Understanding AI Assurance 15:00 Raising AI Literacy 18:00 The Human-in-the-Loop Imperative 23:00 Guardrails & Accountability 26:00 Key Takeaways & ClosingIf you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter.Suggested links:LTR: Building Trustworthy AI and MedTech Readiness.LTR: Proactive AI Governance in MedTech.ACHIEVE Workshop: Using ChatGPT to Analyze Recalls and Adverse Events. Key Takeaways* Patient-safety passion often begins with personal experience — and sustains professional purpose.* AI innovation is racing ahead of our assurance and measurement systems.* The EU and U.S. regulatory models reveal opposite extremes; balance and shared responsibility are essential.* “AI literacy” should become a core competency for all QA/RA professionals.* Assurance in AI demands new tools, standards (e.g., ISO 42001, 22989), and human judgment.* Human oversight is indispensable: vigilance prevents overreliance and hubris.* Safety frameworks must evolve as fast as the technologies they govern.* Communities like the AI Safety Officer Network will drive the next era of responsible innovation.KeywordsAI safety, medical device risk management, patient safety, regulatory strategy, ISO 42001, human-in-the-loop, responsible innovation, AI assurance, EU AI Act, risk literacyAbout James PinkJames Pink is a leading voice in medical device safety and risk management with over 25 years of global experience spanning clinical engineering, notified bodies, and regulatory consulting.He is the Managing Partner at James Pink Advisory Services and Module Leader for Data Management and Digitalisation in Regulatory Affairs at TOPRA.A respected educator and expert witness, James has trained thousands of professionals worldwide and previously held senior leadership roles at Element Materials Technology and NSF International. He also founded the Medical Device Safety Risk Management and AI Safety Officer groups on LinkedIn, fostering global collaboration on responsible innovation and patient safety.Let’s Talk Risk! with Dr. Naveen Agarwal is a weekly live audio event on LinkedIn, where we talk about risk management related topics in a casual, informal way. Join us at 11:00 am EST every Friday on LinkedIn.DisclaimerInformation and insights presented in this podcast are for educational purposes only, and not as legal advice. Views expressed by all speakers are their own and do not reflect those of their respective organizations.Parts of this article were created using AI-generated content, which was subsequently reviewed, edited, and fact-checked by the author to ensure accuracy and alignment with our standards. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit naveenagarwalphd.substack.com/subscribe